Sanofi Pharma Ltd.

Sanofi Pharma Ltd.
Stock Exchange Bombay Stock Exchange Prices
EPS
INR162.57
Market Cap
INR152.24 B
Shares Outstanding
23.03 M
Public Float
9.09 M

Profile

Address
Sanofi House
Mumbai Maharashtra 400072
India
Employees -
Website http://www.sanofiindialtd.com
Updated 09/14/2018
Sanofi India Ltd. engages in the manufacture and distribution of pharmaceutical drugs. The firm offers its products under the AllStar, Amaryl M, Amaryl M Forte, Amaryl MV, Apidra, Arava, Augeoz, Brodactam, Cardace, Cardace Protect, Cardace AM, Cardace Meto, Caspercid, Cetapin P, Cetapin XR, Cetapin V, Clexane, Daonil, Daonil M, Frisium, Insuman Rapid, Insuman Comb 25, Insuman Comb 50, Lantus, Lasilactone 50 Lasix, Metosan XR, M-Nem, Rejusite, Amaryl, Semi-Daonil, Targocid, Taxotere, Telsite, Telsite AM, Telsite AM H, Telsite H, Trental, Vogsite Md, and Zolineg brands. It also focuses on the following therapeutic areas: diabetes, cardiology, consumer healthcare, hospital, central nervous system, and anti-histamines.

Financials

View All
Created with Highcharts 5.0.14Sanofi Pharma Ltd.Net Income. Fiscal year is January-December. All values INR Millions.2 3982 3981 9711 9712 3762 3763 0423 0423 2603 2602013201420152016201701k2k3k4k
Created with Highcharts 5.0.14Sanofi Pharma Ltd.Sales/Revenue. Fiscal year is January-December. All values INR Millions.17 97217 97219 60419 60421 72121 72123 37223 37224 40124 4012013201420152016201705k10k15k20k25k30k

Narayan Rajaram
Managing Director & Executive Director
Charles Billard
Chief Financial Officer & Director